Averill Master Fund, Ltd. (CIK 1939329) reported 43 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-08-21). Recent activity: Sell MANE (690,601 shares), Sell MANE (59,399 shares), Buy MANE (149,000 shares), Buy MANE (151,000 shares), Buy MANE (2,519 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-21 | Veradermics, Inc (MANE) | Director | Sell | 690,601 | $74.1M |
| 2026-08-21 | Veradermics, Inc (MANE) | Director | Sell | 59,399 | $6.4M |
| 2026-08-21 | Veradermics, Inc (MANE) | Director | Buy | 149,000 | $0 |
| 2026-08-21 | Veradermics, Inc (MANE) | Director | Buy | 151,000 | $0 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 2,519 | $91,364 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 10,676 | $370,884 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 14,659 | $531,682 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 53,344 | $2.0M |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 25,908 | $986,836 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 18,489 | $719,222 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 1,720 | $58,910 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 1,835 | $63,748 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 10,004 | $342,637 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 9,168 | $340,224 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 4,453 | $169,615 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 3,178 | $123,624 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 3,832 | $138,220 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 19,199 | $709,019 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 38,771 | $1.5M |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 17,835 | $689,679 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 16,563 | $659,207 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 11,183 | $402,253 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 19,338 | $706,804 |
| 2025-12-29 | Benitec Biopharma Inc. (BNTC) | Director | Buy | 42,600 | $547,410 |
| 2025-12-29 | Benitec Biopharma Inc. (BNTC) | Director | Buy | 7,400 | $95,090 |
Source: SEC Form 4 filings · as of 2026-08-21